CORNERSTONE THERAPEUTICS INC - FORM 10-K - EX-23.1 - CONSENT OF GRANT THORNTON LLP - March 6, 2012

Attached files

file filename
10-K - FORM 10-K - CORNERSTONE THERAPEUTICS INCd275039d10k.htm
EX-21.1 - SUBSIDIARIES OF THE REGISTRANT - CORNERSTONE THERAPEUTICS INCd275039dex211.htm
EX-10.50 - SEPARATION LETTER AGREEMENT AND GENERAL RELEASE - CORNERSTONE THERAPEUTICS INCd275039dex1050.htm
EXCEL - IDEA: XBRL DOCUMENT - CORNERSTONE THERAPEUTICS INCFinancial_Report.xls
EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 - CORNERSTONE THERAPEUTICS INCd275039dex311.htm
EX-32.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 906 - CORNERSTONE THERAPEUTICS INCd275039dex321.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 - CORNERSTONE THERAPEUTICS INCd275039dex312.htm
EX-32.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 906 - CORNERSTONE THERAPEUTICS INCd275039dex322.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We have issued our report dated March 6, 2012, with respect to the consolidated financial statements and schedule included in the Annual Report of Cornerstone Therapeutics Inc. on Form 10-K for the year ended December 31, 2011. We hereby consent to the incorporation by reference of said report in the Registration Statements of Cornerstone Therapeutics Inc. on Forms S-8 (File No. 333-119409, effective September 30, 2004, File No. 333-125892, effective June 17, 2005, File No. 333-131037, effective January 13, 2006, File No. 333-133867, effective May 5, 2006, File No. 333-156293, effective December 19, 2008, File No. 333-161326, effective August 13, 2009 and File No. 333-168542, effective August 5, 2010) and S-3 (File No. 333-166770, effective May 18, 2011).

/s/ GRANT THORNTON LLP

Raleigh, North Carolina

March 6, 2012

Stock widget

Investing forum

CORNERSTONE THERAPEUTICS INC Reports